Electrocardiographic abnormalities in epilepsy: analysis of cardiac conduction patterns and SUDEP Risk
- PMID: 40638013
- DOI: 10.1007/s10072-025-08355-9
Electrocardiographic abnormalities in epilepsy: analysis of cardiac conduction patterns and SUDEP Risk
Abstract
Background: Electrocardiographic (ECG) abnormalities in epilepsy patients may contribute to sudden unexpected death in epilepsy (SUDEP). This systematic review and meta-analysis evaluated the prevalence of ECG abnormalities in epilepsy patients, their age-specific patterns, and association with mortality risk.
Methods: Following PRISMA guidelines, we systematically searched major databases through September 2024 for studies reporting ECG findings in epilepsy patients. We analyzed 11 studies (2,775 epilepsy patients, 2,751 non-epileptic subjects) using random-effects models for prevalence rates, mean differences, and conducted age-stratified and mortality analyses.
Results: QRS axis deviation emerged as the most robust epilepsy-associated cardiac abnormality, occurring seven-fold more frequently in epilepsy patients compared to controls (23.1% vs 3.2%, p = 0.033). T wave abnormalities showed significantly higher prevalence in epilepsy patients versus controls (31.2% vs 5.0%, p = 0.039). ST segment changes demonstrated a 3.6-fold increased risk in epilepsy patients (RR: 3.55, 95% CI: 1.36-9.22). Age-stratified analysis revealed prolonged QTc was significantly more common in adults compared to pediatric patients (13.5% vs 2.4%, p = 0.04). Mortality analysis showed no significant differences in basic ECG parameters between deceased and surviving epilepsy patients. Basic cardiac parameters including heart rate, PR interval, and QRS duration remained comparable between epilepsy and control groups.
Conclusions: Epilepsy patients exhibit distinct cardiac electrical abnormalities, particularly conduction axis and repolarization changes. However, these retrospective findings with substantial heterogeneity represent potential indicators of electrophysiological instability rather than validated SUDEP biomarkers. Rigorous prospective validation is essential before clinical implementation.
Keywords: Cardiac Conduction; Electrocardiography; Epilepsy; Meta-Analysis; QT Interval; Sudden Death.
© 2025. Fondazione Società Italiana di Neurologia.
Conflict of interest statement
Declarations. Ethical consideration: As a secondary analysis of published literature, this study did not involve direct human subjects, patient data collection, or interventions; therefore, institutional review board approval was not required. The study adhered to the PRISMA guidelines for systematic reviews and meta-analyses. The manuscript was prepared without the use of artificial intelligence writing tools or language models. Confilict of interest: The authors deny any conflict of interests. Ethical statement: Ethical approval was waived, as this is a meta-analysis study. Accordingly, the requirement for informed consent was also waived.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).Cochrane Database Syst Rev. 2016 Jul 19;7(7):CD011792. doi: 10.1002/14651858.CD011792.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Apr 2;4:CD011792. doi: 10.1002/14651858.CD011792.pub3. PMID: 27434597 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Heart rate variability modification as a predictive factor of sudden unexpected death in epilepsy: How far are we? A systematic review and meta-analysis.Eur J Neurol. 2023 Jul;30(7):2122-2131. doi: 10.1111/ene.15792. Epub 2023 Apr 6. Eur J Neurol. 2023. PMID: 36932903
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
References
-
- Practice guideline summary (2019) Sudden unexpected death in epilepsy incidence rates and risk factors. Neurology 93(22):982
-
- Thurman DJ, Hesdorffer DC, French JA (2014) Sudden unexpected death in epilepsy: assessing the public health burden. Epilepsia 55(10):1479–1485 - PubMed
-
- Lin S, Schwartz TH, Pitt GS (2024) Sudden Unexpected Death in Epilepsy: Respiratory vs. Cardiac Contributions. Cardiovasc Res 120(18):2385–2394. https://doi.org/10.1093/cvr/cvae170
-
- Ficker DM et al (1998) Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 51(5):1270–1274 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials